^
BIOMARKER:

HER-2 L869R

i
Other names: ERBB2, CD340, HER-2, HER2, NEU, NGL, V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2
Entrez ID:
HER-2 L869R
HER2 Positive Breast Cancer
neratinib + ado-trastuzumab emtansine
Sensitive: D – Preclinical
HER-2 L869R
HER2 Positive Breast Cancer
neratinib + fam-trastuzumab deruxtecan-nxki
Sensitive: D – Preclinical
HER-2 L869R
Breast Cancer
ado-trastuzumab emtansine
Resistant: D – Preclinical